Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Sankyo prepares inhibitors of TNF-alpha production

July 23, 1998

HMR arthritis Rx up for FDA committee review

July 21, 1998

Invitation to access the ongoing telesymposium on rheumatoid arthritis therapies

July 17, 1998

Synthesis of new COX-2 inhibitor described by Merck scientists

July 16, 1998

TSL-225, a dipeptide inhibitor of dipeptidyl peptidase IV

July 15, 1998

Hydroxamic acid-based MMP inhibitors described by P&U

July 14, 1998

Anergen initiates clinical trials with AnergiX

July 14, 1998

Alexion initiates C5 inhibitor phase I/II clinical trial for rheumatoid arthritis

July 14, 1998

Collagenase inhibitors in the pipeline at British Biotech

July 13, 1998

Clinical trial results in RA reported for T-614

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...